Ibuprofen S&r

Ibuprofen, the active ingredient in Ibuprofen S&r, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as an oral dosage form for oral use. It treats pain, fever and inflammation in adults and children as appropriate.

GNH USA supplies Ibuprofen S&r as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen is an NSAID that reduces pain, fever, and inflammation by inhibiting prostaglandin synthesis.

- Headache: provides relief of mild to moderate headache pain. - Musculoskeletal pain: reduces pain and swelling associated with strains, sprains and arthritis. - Fever: lowers elevated body temperature in febrile conditions.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia or heartburn. - Headache or dizziness. - Mild skin rash or itching. - Elevated blood pressure. - Tinnitus (ringing in ears).

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation. - Acute renal impairment or failure. - Severe allergic reactions such as anaphylaxis. - Hepatotoxicity with elevated liver enzymes. - Thrombocytopenia or other blood dyscrasias.

Before using Ibuprofen S&r, consider the following safety measures.

- Assess gastrointestinal risk: avoid in patients with active ulcers or a history of GI bleeding. - Monitor renal function: use cautiously in those with renal impairment. - Avoid concurrent anticoagulants: increased risk of bleeding. - Limit use in cardiovascular disease: may raise risk of thrombotic events. - Pregnancy and lactation: consult a healthcare professional before use. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Ibuprofen can interact with several medication classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Selective COX‑2 inhibitors: heightened cardiovascular risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function. - Diuretics: risk of renal impairment. - Lithium: increased serum lithium levels. - Methotrexate: reduced clearance leading to toxicity.